Open Access<p>Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients</p>
Author(s) -
Chaojun Liu,
Zhen Zhang,
Ping Yü,
Guohui Qin,
Kai Zhang,
Nomathamsanqa Resegofetse Maimela,
Lan Huang,
Shengli Yang,
Yi Zhang
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s238174
Subject(s) - glioma , immune checkpoint , isocitrate dehydrogenase , immunotherapy , immune system , cancer research , biology , medicine , oncology , immunology , biochemistry , enzyme
Programmed cell death protein-1 (PD-1) blockade therapy is one of the most remarkable immunotherapy strategies in many solid tumors, excluding glioma. The PD-1 expression, immune characteristics, and prognosis relevance in glioma remain poorly understood.